| Type 2 Diabetes Mellitus |
1 |
1 |
| Weight Management |
0 |
0.94 |
| GLP-1 Receptor Agonist |
0 |
0.55 |
| Chronic Kidney Disease |
0 |
0.54 |
| Renal Failure |
0 |
0.54 |
| Obesity |
0 |
0.52 |
| Hyperglycemia |
0 |
0.99 |
| Weight Loss |
0 |
0.45 |
| Cardiovascular Risk Management |
0 |
0.43 |
| Biliary Disease |
0 |
0.42 |
| Coronary Artery Disease (CAD) |
0 |
0.38 |
| Receptors |
0 |
0.36 |
| Pain Management |
0 |
0.32 |
| Clinical Guidelines |
0 |
0.27 |
| Heart Failure (HF) |
0 |
0.27 |
| Cerebrovascular Accident |
0 |
0.25 |
| Metabolic Syndrome |
0 |
0.25 |
| Renal Disease |
0 |
0.25 |
| Myocardial Infarction (MI) |
0 |
0.23 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.23 |
| Back Pain |
0 |
0.2 |
| Knee Pain |
0 |
0.19 |
| Cardiovascular disease |
0 |
0.18 |
| DPP-4 Inhibitors |
0 |
0.18 |
| Kidney |
0 |
0.18 |
| Pain |
0 |
0.18 |
| Peripheral Artery Disease |
0 |
0.16 |
| Cardiovascular Imaging |
0 |
0.15 |
| Sleep Apnea |
0 |
0.14 |
| Sleep Disorders |
0 |
0.14 |
| Fatty Liver |
0 |
0.13 |
| Liver Disease |
0 |
0.13 |
| Myocardial Infarction (MI) History |
0 |
0.13 |
| Artery |
0 |
0.09 |
| Arthritis |
0 |
0.09 |
| Diet |
0 |
0.09 |
| Ejection Fraction |
0 |
0.09 |
| Europe |
0 |
0.09 |
| Exercise |
0 |
0.09 |
| Heart |
0 |
0.09 |
| Infarction |
0 |
0.09 |
| Liver |
0 |
0.09 |
| Metabolism |
0 |
0.09 |
| Sleep |
0 |
0.09 |
| Sulfonylureas |
0 |
0.09 |
| Surgery |
0 |
0.09 |
| Transient Ischemic Attack |
0 |
0.09 |